Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2644)
All Articles published online
|
Jan 1, 2004 (publication date) through Jan 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Festi D, Sandri L, Mazzella G, Roda E, Sacco T, Staniscia T, Capodicasa S, Vestito A, Colecchia A. Safety of interferon β treatment for chronic HCV hepatitis. World J Gastroenterol 2004; 10(1): 12-16 [PMID: 14695760 DOI: 10.3748/wjg.v10.i1.12] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i1/12.htm |
| Number | Citing Articles |
| 1 |
Birgit Morgenstern, Martin Michaelis, Patrick C. Baer, Hans W. Doerr, Jindrich Cinatl. Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochemical and Biophysical Research Communications 2005; 326(4): 905 doi: 10.1016/j.bbrc.2004.11.128
|
| 2 |
Tatsuo Kanda, Shingo Nakamoto, Makoto Arai, Tatsuo Miyamura, Shuang Wu, Keiichi Fujiwara, Osamu Yokosuka. Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient. Clinical Journal of Gastroenterology 2013; 6(2): 160 doi: 10.1007/s12328-013-0366-1
|
| 3 |
Yoshio Katamura, Fumitaka Suzuki, Norio Akuta, Hitomi Sezaki, Hiromi Yatsuji, Norihiro Nomura, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada. Natural Human Interferon .BETA. Plus Ribavirin Combination Therapy in Japanese Patients Infected with Hepatitis C Virus and a High Viral Load. Internal Medicine 2008; 47(21): 1827 doi: 10.2169/internalmedicine.47.1436
|
| 4 |
Yasuji Arase, Fumitaka Suzuki, Norio Akuta, Hitomi Sezaki, Yoshiyuki Suzuki, Yusuke Kawamura, Masahiro Kobayashi, Tetsuya Hosaka, Hiromi Yatsuji, Miharu Hirakawa, Naoki Matsumoto, Satoshi Saito, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada. Efficacy and Safety of Combination Therapy of Natural Human Interferon .BETA. and Ribavirin in Chronic Hepatitis C Patients with Genotype 2 and High Virus Load. Internal Medicine 2010; 49(11): 965 doi: 10.2169/internalmedicine.49.3299
|
| 5 |
Valérie Paradis, Tarik Asselah, Delphine Dargere, Marie–Pierre Ripault, Michèle Martinot, Nathalie Boyer, Dominique Valla, Patrick Marcellin, Pierre Bedossa. Serum Proteome to Predict Virologic Response in Patients With Hepatitis C Treated by Pegylated Interferon Plus Ribavirin. Gastroenterology 2006; 130(7): 2189 doi: 10.1053/j.gastro.2006.02.059
|
| 6 |
Alasdair Timothy Llewelyn Rathbone, Surejini Tharmaradinam, Shucui Jiang, Michel P. Rathbone, Dinesh A. Kumbhare. A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the “post-inflammatory brain syndrome” PIBS. Brain, Behavior, and Immunity 2015; 46: 1 doi: 10.1016/j.bbi.2015.02.009
|
| 7 |
Rinaldo Pellicano, Antonio Craxì, Piero Luigi Almasio, Mario Valenza, Giovanna Venezia, Alfredo Alberti, Silvia Boccato, Luigi Demelia, Orazio Sorbello, Antonino Picciotto, Francesco Torre, Gaetano Ideo, Carlo Cattaneo, Mara Berrutti, Mario Rizzetto. Interferon β-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C. World Journal of Gastroenterology 2005; 11(29): 4484-4489 doi: 10.3748/wjg.v11.i29.4484
|
| 8 |
Richard W Weber. Adverse reactions to biological modifiers. Current Opinion in Allergy & Clinical Immunology 2004; 4(4): 277 doi: 10.1097/01.all.0000136757.58818.10
|
| 9 |
J. Schiefer. Medikamentös induzierte neurologische und psychiatrische Störungen. 2006; : 117 doi: 10.1007/3-540-28604-7_7
|
| 10 |
Seyed Mohammadmehdi Hosseini-Moghaddam, Afkham Mousavi, Seyed Moayed Alavian. Is β-interferon a promising therapeutic option for the management of hepatitis C?. Journal of Antimicrobial Chemotherapy 2009; 63(6): 1097 doi: 10.1093/jac/dkp092
|
| 11 |
Yasuji Arase, Yoshiyuki Suzuki, Fumitaka Suzuki, Naoki Matsumoto, Norio Akuta, Norihiro Imai, Yuya Seko, Hitomi Sezaki, Yusuke Kawamura, Masahiro Kobayashi, Tetsuya Hosaka, Satoshi Saito, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada. Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C patients. Internal Medicine 2011; 50(19): 2083 doi: 10.2169/internalmedicine.50.5767
|
| 12 |
Ye Wang, Hongdan Xu, Na Chen, Jin Yang, Hongmei Zhou. LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection. Pharmaceutics 2022; 14(3): 621 doi: 10.3390/pharmaceutics14030621
|
| 13 |
Miller H Smith, Paul W Harms, Duane W Newton, Bill Lebar, Sean P Edwards, David M Aronoff. Mandibular Actinomyces osteomyelitis complicating florid cemento-osseous dysplasia: case report. BMC Oral Health 2011; 11(1) doi: 10.1186/1472-6831-11-21
|
| 14 |
D. V. Mishin, E. I. Isaeva, S. S. Grigorian, A. A. Balakina, A. V. Ilyichev, P. G. Deryabin, D. G. Maldov. The Mechanism of Suppression of Chronic Hepatitis C Infection by the Medicine Stimforte. Biology Bulletin 2020; 47(5): 448 doi: 10.1134/S1062359020050076
|
| 15 |
Hiroaki Okushin, Toru Ohnishi, Kazuhiko Morii, Koichi Uesaka, Shiro Yuasa. Short-term intravenous interferon therapy for chronic hepatitis B. World Journal of Gastroenterology 2008; 14(19): 3038-3043 doi: 10.3748/wjg.14.3038
|
| 16 |
Virginia Clark, David R. Nelson. Novel Interferons for Treatment of Hepatitis C Virus. Clinics in Liver Disease 2009; 13(3): 351 doi: 10.1016/j.cld.2009.05.004
|
| 17 |
Natarajan Sethuraman, Terrance A Stadheim. Challenges in therapeutic glycoprotein production. Current Opinion in Biotechnology 2006; 17(4): 341 doi: 10.1016/j.copbio.2006.06.010
|
| 18 |
Henry L. Y. Chan, Hong Ren, Wan C. Chow, Theodore Wee. Randomized trial of interferon beta‐1a with or without ribavirin in Asian patients with chronic hepatitis C†‡. Hepatology 2007; 46(2): 315 doi: 10.1002/hep.21683
|
| 19 |
Yasuhiko NAKAMURA, Keisuke HINO. A Case of Ovulatory Cycle-dependent Symptoms in Woman with Previous Interferon .BETA. Therapy. Endocrine Journal 2005; 52(3): 377 doi: 10.1507/endocrj.52.377
|
| 20 |
Ricardo Moreno-Otero, María Trapero-Marugán, Elena Gómez-Domínguez, Luisa García-Buey, JoséA Moreno-Monteagudo. Is interferon-beta an alternative treatment for chronic hepatitis C. World Journal of Gastroenterology 2006; 12(17): 2730-2736 doi: 10.3748/wjg.v12.i17.2730
|
| 21 |
Sang Hoon Ahn, Hyun Woong Lee, Yong Soo Kim, Ja Kyung Kim, Kwang-Hyub Han, Chae Yoon Chon, Young Myoung Moon. Recombinant Interferon-Beta-1a Plus Ribavirin for the Treatment of Chronic HCV Infection: A Prospective, Randomized, Comparative Pilot Study. Gut and Liver 2009; 3(1): 20 doi: 10.5009/gnl.2009.3.1.20
|
| 22 |
Qunying Han, Zhengwen Liu, Wen Kang, Han Li, Lei Zhang, Ni Zhang. Interferon Beta 1a versus Interferon Beta 1a plus Ribavirin for the Treatment of Chronic Hepatitis C in Chinese Patients: A Randomized, Placebo-Controlled Trial. Digestive Diseases and Sciences 2008; 53(8): 2238 doi: 10.1007/s10620-007-0129-2
|
| 23 |
Darren P. Baker, Edward Y. Lin, KoChung Lin, Maria Pellegrini, Russell C. Petter, Ling Ling Chen, Robert M. Arduini, Margot Brickelmaier, Dingyi Wen, Donna M. Hess, Liqing Chen, Donna Grant, Adrian Whitty, Alan Gill, Daniel J. Lindner, R. Blake Pepinsky. N-Terminally PEGylated Human Interferon-β-1a with Improved Pharmacokinetic Properties and in Vivo Efficacy in a Melanoma Angiogenesis Model. Bioconjugate Chemistry 2006; 17(1): 179 doi: 10.1021/bc050237q
|
| 24 |
Akira Sato, Masahiro Yamauchi, Takayuki Yamada, Reiko Kumano, Kayo Adachi, Toshiya Ishii, Mikihito Hayashi, Daisuke Kumon. Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia. Clinical Journal of Gastroenterology 2014; 7(4): 355 doi: 10.1007/s12328-014-0500-8
|
| 25 |
Jhao-Yin Lin, Rei-Lin Kuo, Hsing-I Huang. Activation of type I interferon antiviral response in human neural stem cells. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1521-5
|
| 26 |
Jared D. Evans, Rachel A. Crown, Ji A. Sohn, Christoph Seeger. West Nile Virus Infection Induces Depletion of IFNAR1 Protein Levels. Viral Immunology 2011; 24(4): 253 doi: 10.1089/vim.2010.0126
|
| 27 |
Daniel Giraldo, Douglas R. Wilcox, Richard Longnecker, Thomas Shenk. The Innate Immune Response to Herpes Simplex Virus 1 Infection Is Dampened in the Newborn Brain and Can Be Modulated by Exogenous Interferon Beta To Improve Survival. mBio 2020; 11(3) doi: 10.1128/mBio.00921-20
|
| 28 |
Jun‐ichi Maeyama, Yuko Kurata‐Iesato, Masanori Isaka, Takako Komiya, Shingou Sakurai. Induction of antibody responses in mice immunized intranasally with Type I interferon as adjuvant and synergistic effect of chitosan. Microbiology and Immunology 2020; 64(9): 610 doi: 10.1111/1348-0421.12832
|
| 29 |
Jacques Descotes, Thierry Vial. Cytokines in Human Health. Methods in Pharmacology and Toxicology 2007; : 193 doi: 10.1007/978-1-59745-350-9_10
|
| 30 |
Yasuji Arase, Fumitaka Suzuki, Norio Akuta, Hitomi Sezaki, Yoshiyuki Suzuki, Yusuke Kawamura, Masahiro Kobayashi, Tetsuya Hosaka, Hiromi Yatsuji, Miharu Hirakawa, Satoshi Saito, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada. Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load. Internal Medicine 2010; 49(11): 957 doi: 10.2169/internalmedicine.49.3232
|
| 31 |
Rebecca T. Veenhuis, Janice E. Clements, Lucio Gama. HIV Eradication Strategies: Implications for the Central Nervous System. Current HIV/AIDS Reports 2019; 16(1): 96 doi: 10.1007/s11904-019-00428-7
|
| 32 |
Shiro Tochizawa, Yasukazu Ohmoto, Toyoki Mori. A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood lymphocytes for rapid detection of interferon-α signal in vivo. Journal of Immunological Methods 2006; 313(1-2): 29 doi: 10.1016/j.jim.2006.03.015
|
| 33 |
Shigeru Otsubo, Takahiko Kawata, Masayo Takasaki, Miwa Ishihara, Syuitsu Ueda, Hisayuki Sugimoto, Kimiko Otsubo, Takashi Akiba, Kosaku Nitta, Masanori Hirano. Treatment of a Serotype-1 Hepatitis C Virus Infection Using Interferon-Beta in a Patient with a High RNA Titer Who Had Been Receiving Long-Term Hemodialysis Therapy. Internal Medicine 2011; 50(7): 733 doi: 10.2169/internalmedicine.50.4453
|
| 34 |
Hans L. Tillmann, John G. McHutchison. Zakim and Boyer's Hepatology. 2012; : 564 doi: 10.1016/B978-1-4377-0881-3.00031-0
|
| 35 |
Yasuji Arase, Yoshiyuki Suzuki, Fumitaka Suzuki, Norio Akuta, Hitomi Sezaki, Yusuke Kawamura, Masahiro Kobayashi, Norihiro Imai, Yuya Seko, Tetsuya Hosaka, Naoki Matsumoto, Satoshi Saito, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada. Efficacy of reduction therapy of natural human β‐interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 2 and high virus load. Hepatology Research 2012; 42(8): 750 doi: 10.1111/j.1872-034X.2012.00982.x
|
| 36 |
Bert M Klebl, Alexander Kurtenbach, Kostas Salassidis, Henrik Daub, Thomas Herget. Host Cell Targets in HCV Therapy: Novel Strategy or Proven Practice?. Antiviral Chemistry and Chemotherapy 2005; 16(2): 69 doi: 10.1177/095632020501600201
|
| 37 |
Jong Ha Jung, Ji Hoon Park, Min Hyeok Jee, Sun Ju Keum, Min-Sun Cho, Seung Kew Yoon, Sung Key Jang. Hepatitis C Virus Infection Is Blocked by HMGB1 Released from Virus-Infected Cells. Journal of Virology 2011; 85(18): 9359 doi: 10.1128/JVI.00682-11
|
| 38 |
Daoyuan Tu, Jin Dou, Mingkao Wang, Haiwen Zhuang, Xiaoyu Zhang. M2 macrophages contribute to cell proliferation and migration of breast cancer. Cell Biology International 2021; 45(4): 831 doi: 10.1002/cbin.11528
|